Zobrazeno 1 - 10
of 218
pro vyhledávání: '"Christian, Kurzeder"'
Autor:
Marcus Vetter, Christian Kurzeder
Publikováno v:
healthbook TIMES. Oncology Hematology (2024)
The development of antibody-based therapies has transformed the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer. More recently, HER2-directed antibody-drug conjugates (ADCs) have demonstrated efficacy in HER2-negat
Externí odkaz:
https://doaj.org/article/6a2059984f5a4a3587bce3d6f0d665a2
Autor:
Martin Heidinger, Nadia Maggi, Gilles Dutilh, Madleina Mueller, Ruth S. Eller, Julie M. Loesch, Fabienne D. Schwab, Christian Kurzeder, Walter P. Weber
Publikováno v:
World Journal of Surgical Oncology, Vol 21, Iss 1, Pp 1-9 (2023)
Abstract Background The Choosing Wisely initiative recommended the omission of routine sentinel lymph node biopsy (SLNB) in patients ≥ 70 years of age, with clinically node-negative, early stage, hormone receptor (HR) positive and human epidermal g
Externí odkaz:
https://doaj.org/article/be96ab186daa4ebb8cbea47379ca1941
Autor:
Tibor A. Zwimpfer, Fabienne D. Schwab, Daniel Steffens, Felix Kaul, Noemi Schmidt, James Geiger, Franziska Geissler, Viola Heinzelmann-Schwarz, Walter P. Weber, Christian Kurzeder
Publikováno v:
World Journal of Surgical Oncology, Vol 21, Iss 1, Pp 1-6 (2023)
Abstract Introduction Contralateral axillary lymph node metastasis (CALNM) in breast cancer (BC) is considered a distant metastasis, marking stage 4cancer. Therefore, it is generally treated as an incurable disease. However, in clinical practice, sta
Externí odkaz:
https://doaj.org/article/1c9140e8d76547ec90920e9a10d48f27
Autor:
Cornelia Leo, Kathrin Schwedler, Rosaria Condorelli, Nicole Bürki, Jens Huober, Khalil Zaman, Christian Kurzeder, Marcus Vetter
Publikováno v:
healthbook TIMES. Oncology Hematology, Vol 17, Iss 3 (2023)
Information on germline BRCA (g*BRCA*) 1/2 pathogenic or likely pathogenic mutations has predictive value for response to platinating agents and poly(ADP-ribose) polymerase inhibitors (PARPi) and survival outcomes of breast cancer (BC) patients. In t
Externí odkaz:
https://doaj.org/article/cf049c079418491f9bbe809dabc7ebb9
Autor:
Dimitri Dettwiler, Elena-Diana Chiru, Eveline Daetwyler, Vérène Dougoud-Chauvin, Markus W. Gross, Christian Kurzeder, Alfred Zippelius, Andreas Schötzau, Marcus Vetter
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundIn Switzerland, approximately 6000 new breast cancer cases and 1300 deaths are reported annually. Brain metastasis from breast cancer (BMBC) has a major effect on prognosis. This study aimed to identify prognostic factors for overall surviv
Externí odkaz:
https://doaj.org/article/dba5da9ff3b7439594f2e71c7e821db8
Autor:
Gaetana Restivo, Aizhan Tastanova, Zsolt Balázs, Federica Panebianco, Maren Diepenbruck, Caner Ercan, Bodgan-T. Preca, Jürg Hafner, Walter P. Weber, Christian Kurzeder, Marcus Vetter, Simone Münst Soysal, Christian Beisel, Mohamed Bentires-Alj, Salvatore Piscuoglio, Michael Krauthammer, Mitchell P. Levesque
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-12 (2022)
Fresh vs. slow-frozen tissues from various malignancies are compared for the establishment of 2D, 3D and ex vivo cultures, as well as for scRNAseq analysis, and found to be comparable and suitable for cancer research.
Externí odkaz:
https://doaj.org/article/87d96e9a64c244768ec47752d441b0e3
Autor:
Elena Diana Chiru, Anton Oseledchyk, Andreas Schoetzau, Christian Kurzeder, Raphael Mosimann, Marcus Vetter, Cvetka Grašič Kuhar
Publikováno v:
Diagnostics, Vol 14, Iss 1, p 97 (2023)
In patients with hormone receptor positive, human epidermal receptor 2 negative (HR+/HER2−) negative breast cancer (BC), the TAILORx study showed the benefit of adding chemotherapy (CHT) to endocrine therapy (ET) in a subgroup of patients under 50
Externí odkaz:
https://doaj.org/article/47fddb00d3164bbc9d1dfbc8044ad8bf
Autor:
Walter Paul Weber, Jane Shaw, Andrea Pusic, Lynda Wyld, Monica Morrow, Tari King, Zoltán Mátrai, Jörg Heil, Florian Fitzal, Shelley Potter, Isabel T. Rubio, Maria-Joao Cardoso, Oreste Davide Gentilini, Viviana Galimberti, Virgilio Sacchini, Emiel J.T. Rutgers, John Benson, Tanir M. Allweis, Martin Haug, Regis R. Paulinelli, Tibor Kovacs, Yves Harder, Bahadir M. Gulluoglu, Eduardo Gonzalez, Andree Faridi, Elisabeth Elder, Peter Dubsky, Jens-Uwe Blohmer, Vesna Bjelic-Radisic, Mitchel Barry, Susanne Dieroff Hay, Kimberly Bowles, James French, Roland Reitsamer, Rupert Koller, Peter Schrenk, Daniela Kauer-Dorner, Jorge Biazus, Fabricio Brenelli, Jaime Letzkus, Ramon Saccilotto, Sarianna Joukainen, Susanna Kauhanen, Ulla Karhunen-Enckell, Juergen Hoffmann, Ulrich Kneser, Thorsten Kühn, Michalis Kontos, Ekaterini Christina Tampaki, Moshe Carmon, Tal Hadar, Giuseppe Catanuto, Carlos A. Garcia-Etienne, Linetta Koppert, Pedro F. Gouveia, Jakob Lagergren, Tor Svensjö, Nadia Maggi, Elisabeth A. Kappos, Fabienne D. Schwab, Liliana Castrezana, Daniel Steffens, Janna Krol, Christoph Tausch, Andreas Günthert, Michael Knauer, Maria C. Katapodi, Susanne Bucher, Nik Hauser, Christian Kurzeder, Rosine Mucklow, Pelagia G. Tsoutsou, Atakan Sezer, Güldeniz Karadeniz Çakmak, Hasan Karanlik, Patricia Fairbrother, Laszlo Romics, Giacomo Montagna, Cicero Urban, Melanie Walker, Silvia C. Formenti, Guenther Gruber, Frank Zimmermann, Daniel Rudolf Zwahlen, Sherko Kuemmel, Mahmoud El-Tamer, Marie Jeanne Vrancken Peeters, Orit Kaidar-Person, Michael Gnant, Philip Poortmans, Jana de Boniface
Publikováno v:
Breast, Vol 63, Iss , Pp 123-139 (2022)
Aim: Demand for nipple- and skin- sparing mastectomy (NSM/SSM) with immediate breast reconstruction (BR) has increased at the same time as indications for post-mastectomy radiation therapy (PMRT) have broadened. The aim of the Oncoplastic Breast Cons
Externí odkaz:
https://doaj.org/article/cf72eb77edfb40ae83e0839ac5b19f92
Autor:
Pamela M. J. McLaughlin, Maximilian Klar, Tibor A. Zwimpfer, Gilles Dutilh, Marcus Vetter, Christian Marth, Andreas du Bois, Carmen Schade-Brittinger, Alexander Reuss, Claudine Bommer, Christian Kurzeder, Viola Heinzelmann-Schwarz
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background A high percentage of epithelial ovarian cancers (EOC) express the estrogen receptor (ER), which is an ideal target for endocrine therapy. Letrozole is a proven, potent aromatase inhibitor, extensively tested and used in the treatm
Externí odkaz:
https://doaj.org/article/a3bafe4e516e4091bd8136116db1cd5d
Autor:
Bischof, Evelyne, Schwab, Fabienne D., Georgescu Margarint, Elena Laura, Montavon, Céline, Zünti, Iris, Schollbach, Anna, Schötzau, Andreas, Hirschmann, Anna, Landin, Julia, Meier, Christian, Christian, Kurzeder, Vetter, Marcus
Publikováno v:
In Bone Reports June 2022 16